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Strengths and limitations of this study
 ► This is the first systematic study addressing how the 
National Health Service (NHS) introduces innovative 
invasive procedures into clinical practice; a topic of 
international public, professional and political inter-
est given the wealth of historic and recent examples 
of patient harm caused by lack of regulation.
 ► The study combines analysis of written policies 
and interviews with key stakeholders to ensure an 
in-depth exploration of the topic to inform national 
guidance to improve and standardise the introduc-
tion of innovative invasive procedures and devices.
 ► The degree to which policies are actually adhered to 
across local NHS organisations is not systematically 
explored in the current study and is recommended 
for future research.
AbStrACt
Introduction Innovation is key to improving outcomes in 
healthcare. Innovative pharmaceutical products undergo 
rigorous phased research evaluation before they are 
introduced into practice. The introduction of innovative 
invasive procedures and devices is much less rigorous and 
phased research, including randomised controlled trials, 
is not always undertaken. While the innovator (usually a 
surgeon) may introduce a new or modified procedure/
device within the context of formal research, they may also 
be introduced by applying for local National Health Service 
(NHS) organisation approval alone. Written policies for 
the introduction of new procedures and/or devices often 
form part of this local clinical governance infrastructure; 
however, little is known about their content or use in 
practice. This study aims to systematically investigate how 
new invasive procedures and devices are introduced in 
NHS England and Wales.
Methods and analysis An in-depth analysis of written 
policies will be undertaken. This will be supplemented 
with interviews with key stakeholders. All acute NHS 
trusts in England and Health Boards in Wales will be 
systematically approached and asked to provide written 
policies for the introduction of new invasive procedures 
and devices. Information on the following will be captured: 
(1) policy scope, including when new procedures should 
be introduced within a formal research framework; (2) 
requirements for patient information provision; (3) outcome 
reporting and/or monitoring. Data will be extracted using 
a standardised form developed iteratively within the 
study team. Semistructured interviews with medical 
directors, audit and governance leads, and surgeons will 
explore views regarding the introduction of new invasive 
procedures into practice, including knowledge of and 
implementation of current policies.
Ethics and dissemination In-depth analysis of written 
policies does not require ethics approval. The University of 
Bristol Ethics Committee (56522) approved the interview 
component of the study. Findings from this work will 
be presented at appropriate conferences and will be 
published in peer-reviewed journals.
IntroduCtIon
Invasive procedures are a fundamental 
part of healthcare and can include surgical 
operations with and without devices, as well 
as endoscopic and radiologically guided 
interventions. At least 230 million invasive 
procedures are delivered worldwide,1 with 
12.5 million undertaken in the UK annu-
ally.2 This number is likely to increase with 
continued innovation, including the advent 
of new technologies and minimal access 
procedures.
Innovation in invasive procedures is key. It 
may include modifying existing techniques,3 
to performing completely new first-in-human 
invasive procedures.4 While innovation is 
common, the governance surrounding it 
is not standardised and is currently under 
much scrutiny.5–7 A recent inquest into the 
death of a patient following robot-assisted 
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cardiac surgery, a procedure that had not been previously 
performed in the UK, found insufficient governance 
surrounding the introduction of this innovative proce-
dure.6 Recommendations from the Coroner, echoed by a 
statement from the Royal College of Surgeons,8 included 
introducing stricter governance relating to the use of 
new technologies and procedures, specific measures to 
assess the competence and training received by clinicians 
wishing to undertake them, and detailed patient infor-
mation provision regarding the risks associated with new 
procedures.
Innovation in invasive procedures may be introduced 
under the auspices of formal research studies, with a 
protocol and application for ethical approval. However, 
multiple reviews show that ethical approval is rarely gained 
when delivering innovative invasive procedures.9–12 While 
medical devices to be used inside the body require a 
European Conformity (CE) mark13–15 prior to use in the 
UK, the evidence required to gain this certification does 
not often come from high-quality randomised controlled 
trials and post-marketing surveillance is minimal.7 
Although medical device regulations are improving,16 
this is very different to the tightly governed and trans-
parent developmental pathways required for the intro-
duction of new pharmaceuticals, including requirements 
for formal assessments of risk–benefit balance and post-
market safety monitoring.17
Outside of research, innovative invasive procedures 
and devices may be introduced via local hospital poli-
cies. The UK National Institute for Clinical Excellence 
(NICE) is an independent body responsible for providing 
evidence-based guidance to the UK National Health 
Service (NHS) on health and social care. The NHS refers 
to the four publicly funded healthcare services in the 
UK (NHS in England, NHS Wales, NHS Scotland, and 
Health and Social care in Northern Ireland) and is made 
up of local NHS organisations (eg, NHS trusts in England 
and health boards in Wales) (online supplementary file 
1). It is recommended by NICE that these local NHS 
organisations have appropriate governance structures in 
place to review, authorise and monitor the introduction 
of new invasive procedures.18 In addition, NICE recom-
mends the approval of new invasive procedures that do 
not have existing NICE guidance should only be given 
if appropriate training of those delivering the procedure 
is demonstrated, patients are made aware of the new 
status of the procedures and there are proposed arrange-
ments for clinical audit.19 These recommendations are 
echoed by organisations worldwide.20–22 In the UK, it is 
the responsibility of local hospital organisations to imple-
ment this guidance, although the extent to which this 
occurs is unknown, and there are instances where innova-
tive procedures are introduced into practice without any 
formal governance.6 Furthermore, where local policies 
do exist, little is known about their content or how they 
are used in practice; how trusts define a new procedure 
(ie, when the guidance should be applied), what infor-
mation should be given to patients, and how outcomes of 
new procedures are recorded and monitored is unclear. 
Examination of when policies are being applied provides 
valuable information about the presence or absence of 
local governance frameworks for the introduction of 
innovative invasive procedures. Furthermore, guidance 
related to patient information provision will provide 
insight into whether patients are informed about the 
innovative status of procedures to be delivered. It is also 
important that outcomes are routinely and effectively 
monitored to support their continued use or to ensure 
those that are ineffective and/or unsafe are abandoned.
A systematic literature review conducted by the Austra-
lian Safety and Efficacy Register of New Interventional 
Procedures—Surgical23 identified only six publications 
related to how acute healthcare organisations introduce 
new invasive procedures. These included retrospective case 
reports of new procedures being introduced in individual 
hospitals in the UK24 and Australia,25 and case studies 
of qualitative interviews with surgeons and clinicians at 
hospitals in Canada regarding how decisions to introduce 
new technologies were made.26 27 Findings indicated that 
the introduction of new procedures and technologies 
were based predominantly on surgeons’ perceptions that 
such innovations would improve patient outcomes, safety 
and care, with no structured decision-making process in 
place at an institutional/governance level. To date, there 
has been no comprehensive review of current local NHS 
policies, many of which are inaccessible by traditional 
literature systematic searches used in the above review.
Aim
This study aims to undertake an in-depth analysis of local 
NHS policies to establish the governance in place for the 
introduction of new invasive procedures and devices. This 
will include examination of (1) how policies outline scope 
for their use, including how they define which invasive 
procedures and devices are eligible under their remit (eg, 
new or modified) and guidance given about when research 
approvals should be sought; (2) recommendations for 
patient information provision; and (3) processes for moni-
toring and reporting outcomes of innovative procedures 
and devices, including how decision-making regarding 
adoption or stopping of the procedure or device are made.
MEthodS And AnAlySIS
This work will comprise two parts occurring concurrently 
and iteratively: (1) systematic analysis of written local 
NHS policies for the introduction of new invasive proce-
dures and devices; (2) interviews with key stakeholders 
(eg, medical directors, audit and governance leads, and 
surgeons) regarding surgical innovation in practice, 
including knowledge of and implementation of current 
policies.
Systematic analysis of nhS policies for the introduction of 
new invasive procedures and devices
Sampling and data collection
All acute NHS trusts in England (n=150) and NHS Health 
Boards in Wales (n=7)27 will be systematically approached 
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Figure 1 Approach to trusts and health boards and planned data extraction from policies for the introduction of new invasive 
procedures and devices. HB, Health Board; NatSSIPs, National Safety Standardsfor Invasive Procedures.
(figure 1). Initially, online searches will be performed to 
determine if policies for the introduction of new inva-
sive procedures and/or devices into clinical practice are 
available online. An online search engine (Google) will 
be used to locate the website for each NHS trust/health 
board (HB). The individual trust/HB website search 
function will be used to determine if the organisation 
has a copy of the relevant policy available online using 
search terms such as ‘new procedure’ and ‘policy/poli-
cies’. Exploratory searching of the trust/HB website will 
also be conducted to ensure relevant information is not 
missed. Where policies are not available, local NHS organ-
isations will be approached as follows. Medical Directors 
will be emailed by senior authors (JMB or RH) to request 
copies of written policies. Non-responders to the initial 
email will have one email reminder 2 weeks later and 
will then be approached by email and phone by a senior 
research associate and a research fellow. Trusts/HBs not 
responding to this will have one final email from the orig-
inal project lead. Policies not wholly related to the intro-
duction of new invasive procedures and/or devices will 
be excluded (eg, device management policies, National 
or Local Safety Standards for Invasive Procedures (NatS-
SIPs, LocSSIPs)). Invasive procedures will be defined as 
procedures where access is gained via an incision, natural 
orifice or percutaneous puncture or involving devices 
used inside the body.
Trust/HB demographics, including geographical area 
and acute trust type (England only, eg, small, specialist, 
teaching, foundation status) will be collected.28
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Data extraction from trust policies
A data extraction form will be developed using a priori 
themes drawn from the literature and knowledge of 
the area among team members (see online supple-
mentary file 2 for a preliminary data extraction form), 
and themes that inductively emerge from the initial 
coding of a subset of documents independently by two 
researchers.
The form will be piloted on a sample of policies gath-
ered during scoping work until the team is satisfied 
that it fully captures all initial key themes. The finalised 
form will be converted into an electronic database29 
where data will be imputed directly from written poli-
cies. All policy documents, including addendums, will 
be systematically examined. Ten per cent of policies 
will be randomly selected for double independent data 
extraction to maximise reliability of data extraction. 
Where there are discrepancies, these will be resolved 
through consensus, and where this is not achieved, a 
third independent reviewer will be consulted.
Data will be extracted about (1) policy scope, (2) 
patient information provision and consent, and (3) 
outcome monitoring and decision-making (detailed 
below). For each policy, we will also extract details of 
policy title and date, date of last policy review and date 
of next policy review. In addition, if a formal committee 
is named in the policy as being involved in reviewing 
the introduction of a new procedure, we will collect 
data on the title of the committee, committee chair, 
core members and frequency of meetings.
Policy scope
How policies define which invasive procedures and 
devices are eligible under their remit (eg, policy defini-
tions of new procedures) and guidance regarding how 
to decide whether the new invasive procedure/device 
requires ‘research approvals’, in addition to or instead 
of local policy approvals alone, will be captured. Policy 
scope data will not be used to inform inclusion or exclu-
sion of policies from analysis.
Patient information provision and consent
Guidance about specific consent procedures and how 
patients should be informed when a procedure is new, 
modified or being conducted by a clinician/in a trust 
for the first time will be captured. Specific require-
ments relating to patient information leaflets (PILs), 
the submission of these PILs to the trust for evalua-
tion and any processes in place to monitor adherence 
to guidance regarding patient information will also be 
extracted.
Outcome monitoring and decision-making
In addition to outcomes typically associated with clin-
ical effectiveness studies, outcomes of specific relevance 
to evaluating innovation of invasive procedures and 
devices will be extracted; these may include operator 
experiences, intended function (eg, benefit) of the 
new/modified procedure/device, unanticipated harms, 
and failure and/or abandonment of the procedure/
device. Mechanisms proposed for outcome monitoring 
(eg, registered audit, feedback to the committee) will be 
captured, in addition to guidance for decision-making 
regarding when procedures should be introduced into 
routine clinical practice or abandoned, and recommen-
dations for wider reporting.
Data analyses (systematic analysis of NHS trust policies)
In order to gain an overview of the scope of the poli-
cies and develop an in-depth understanding of specific 
themes of relevance to the study aims, mixed-methods 
analyses will be undertaken.
Trust/HB demographics including geographical area 
and acute trust type will be tabulated. Quantitative data 
including response rates, and the presence or absence 
of a new invasive procedures/devices policy within each 
local NHS organisation will be presented.
Data related to each of the three key data extraction 
areas outlined above will be tabulated and descriptive 
statistics provided. For example, the number of policies 
that provide guidance for when procedures should only 
be conducted within a research study will be counted.
Free text data related to each of the three data 
extraction areas will be extracted from policies and anal-
ysed as following. Verbatim sections of policies will be 
transferred to qualitative data analysis software (NVivo, 
V.11) and analysed thematically in several key stages: (1) 
two researchers will independently code a subset of policy 
documents to develop a preliminary coding frame; (2) any 
discrepancies will be resolved through discussion before 
the coding frame is applied to the full dataset; (3) codes 
will be grouped into themes and subthemes by examining 
commonalities, differences and relationships in the data; 
(4) themes will be regularly reviewed to ensure they accu-
rately encapsulate the data. Findings from this qualitative 
analysis will be written up descriptively.
Interviews with key stakeholders
In-depth semistructured interviews will be conducted with 
representatives from key stakeholder groups as detailed 
below.
Recruitment and sampling
Professionals involved in local governance processes 
related to the introduction of new procedures and devices 
(eg, new procedures committee members, medical direc-
tors) and healthcare professionals with experience of 
introducing new/modified procedures or devices into 
clinical practice (eg, surgeons, nurses) will be identi-
fied from policy documents, trust websites and clinical 
contacts of the research team. A snowball sampling 
approach,30 where interviewees are asked to recommend 
the names of other potential interviewees, will be used 
to facilitate recruitment. To ensure maximum variation 
within the sample,30 we will interview participants from 
varying geographical locations, trust types, different 
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surgical specialities and from trusts with and without 
policies. Participant characteristics will be reviewed as 
recruitment and analyses are ongoing throughout the 
study, and under-represented groups or individuals with 
particular knowledge and/or experiences of particular 
interest will be purposively sampled.30 It is anticipated 
that up to 60 stakeholders will be interviewed, although 
data analysis will be driven by the objective of achieving 
data saturation (where no new themes emerge from the 
data).
Data collection
Written informed consent will be obtained from all 
participants before interviews commence. Interviews 
will be conducted by one of two experienced qualita-
tive researchers, either via telephone or in person, at 
times convenient for participants. Interviews will be 
audio-recorded using encrypted audio-recording devices 
(Olympus DS3500). Discussions will follow a topic guide 
that will vary by stakeholder group so that key issues 
are covered, while ensuring participants are able to talk 
about new issues they feel are important. Topic guides 
(see online supplementary file 3 for example preliminary 
topic guide for clinicians) will be adapted iteratively as 
analyses of interviews and written policies progresses so 
that any emerging issues can be discussed with subse-
quent participants.
Interviews with professionals involved in governance 
processes will specifically explore how new procedures are 
introduced. This will include how policies define the types 
of technologies and procedures that will be reviewed for 
introduction to the trust (with examples if possible); the 
approval processes in place; and methods for follow-up, 
monitoring of approved technologies/procedures and 
abandonment of procedures. Interviews with healthcare 
professionals will explore their views on surgical innova-
tion, monitoring of new procedures/devices and, when 
applicable, their experience of introducing a new proce-
dure or device into clinical practice.
Analysis (interviews with key stakeholders)
Interviews will be transcribed in full and verbatim, 
checked against the original recording for accuracy, and 
imported into NVivo (V.11). Data will then be system-
atically assigned codes and analysed thematically using 
constant comparative techniques.31 A subset of the tran-
scripts will be doubled coded by a second qualitative 
researcher, with any discrepancies in coding discussed 
and resolved. Data collection and analysis will proceed 
in parallel, with emerging findings informing further 
sampling (theoretical sampling) and data collection. 
Dissonant views that challenge the emerging dominant 
perspectives will be actively pursued (negative case 
analysis) to ensure the inclusion of diverse viewpoints. 
Descriptive accounts of the data, which take into consid-
eration of the views and background of the analysts, will 
then be written.
data protection and confidentiality
All data relating to participants’ personal identities will 
be anonymised using unique study identifiers. This data 
will be stored in a separate encrypted file, in a separate 
location from the study data on the University of Bristol 
server. It will only be accessible to the research team and 
used only in the event of re-contacting study participants 
to verify information, for example, quotes. Verbatim 
quotations that may be used for publications or presenta-
tions will also be anonymised.
EthICS And dISSEMInAtIon
The in-depth analysis of written policies does not require 
ethics approval, in accordance with the Health Research 
Authority definition of research.32 The qualitative compo-
nent of the work has been approved by the University of 
Bristol Ethics Committee (reference 56522).
Expected outcomes of the study
This work will provide an in-depth exploration and 
summary of current governance procedures for clini-
cians wishing to introduce innovative invasive procedures 
and devices into NHS practice in England and Wales. 
Understanding how innovative invasive procedures are 
introduced will identify limitations in current guidance, 
inform the development of standardised guidance and 
raise hypotheses for future research. It is expected that 
this work will inform national guidelines regarding the 
introduction of innovative invasive procedures.
dissemination
Findings from this work will be presented at appro-
priate conferences and published across several papers 
highlighting main findings. These will include in-depth 
analyses of the scope of written policies, including when 
innovative procedures should be delivered within a 
research governance framework, and how policies define 
‘new’ and ‘modified’ procedures/devices. Additional 
publications will focus on guidance related to patient 
information, consent and outcome monitoring after the 
introduction of new procedures and devices. Addition-
ally, qualitative data from interviews with key stakeholders 
regarding surgical innovation in practice, including 
knowledge and implementation of current policies, will 
be published separately.
dISCuSSIon
Currently, little is known about the ways in which new 
invasive procedures and devices are introduced into 
NHS clinical practice outside the context of research. 
This is a topical issue as several concerning and prob-
lematic high-profile cases have emerged recently.5–7 33 
This study will systematically study current NHS practice 
to determine the presence, content and implementa-
tion of policies relating to the introduction of new inva-
sive procedures and devices in NHS England and Wales. 
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Identified policies will be scrutinised to determine what 
guidance is given regarding policy scope, patient infor-
mation provision and the monitoring, reporting and 
review of outcomes. Additionally, interviews with stake-
holders (such as surgeons and members of new proce-
dures committees) will further inform this work.
The ways in which new procedures, including surgery, 
are introduced into practice is a topic of international 
public interest. This study is the first of its kind and it 
is anticipated it will inform future NHS governance and 
practice in this field.
PAtIEnt And PublIC InvolvEMEnt
The current study comprises a core component of the 
work undertaken within the National Institute for Health 
Research (NIHR) Bristol Biomedical Research Centre 
(BRC) Surgical Innovation theme, which aims to improve 
the safe and transparent translation of innovative proce-
dures/devices to clinical practice. A patient and public 
involvement (PPI) group has been established as part of 
the NIHR Bristol BRC, where patients who have under-
gone surgery are asked about their views regarding how 
new surgical procedures are undertaken in NHS clinical 
practice. This involves discussion around what informa-
tion patients would like to be provided with before and 
after receiving a new invasive procedure/device, and 
what health/lifestyle outcomes after surgery would be 
considered important. To date, the consensus between 
PPI group members is that the work being undertaken 
to improve the way in which new procedures are intro-
duced into clinical practice is important and could have 
positive implications for future healthcare in the NHS. 
The current study comprises a first step in the process 
of improving how new procedures are introduced into 
practice and the PPI group will continue to provide input 
throughout the study and future work to develop related 
guidance and disseminate findings.
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